Intermittent Fasting Can Help Manage Metabolic Disease

Eating daily calories within a consistent window of 8-10 hours is a powerful strategy to prevent and manage chronic diseases such as diabetes and heart disease, according to a new manuscript published in the Endocrine Society’s journal, Endocrine Reviews.

Time-restricted eating is a type of intermittent fasting that limits your food intake to a certain number of hours each day. Intermittent fasting is one of the most popular diet trends, and people are using it to lose weight, improve their health and simplify their lifestyles.

“People who are trying to lose weight and live a healthier lifestyle should pay more attention to when they eat as well as what they eat. Time-restricted eating is an easy-to-follow and effective dietary strategy that requires less mental math than counting calories,” says Satchidananda Panda, PhD, of the Salk Institute for Biological Studies in La Jolla, Calif. “Intermittent fasting can improve sleep and a person’s quality of life as well as reduce the risk of obesity, diabetes, and heart disease.”

In the manuscript, the researchers explore the science behind time-restricted eating, recent clinical studies, and the scope for future research to better understand its health benefits. Recent research has revealed that genes, hormones, and metabolism rise and fall at different times of the 24-hour day. Aligning our daily habit of when we eat with the body’s internal clock can optimize health and reduce the risk or disease burden of chronic conditions like diabetes, heart disease and liver disease.

“Eating at random times breaks the synchrony of our internal program and make us prone to diseases,” Panda says. “Intermittent fasting is a lifestyle that anyone can adopt. It can help eliminate health disparities and lets everyone live a healthy and fulfilling life.”

Other authors of the study include: Emily Manoogian of the Salk Institute for Biological Studies; Lisa Chow of the University of Minnesota in Minneapolis, Minn.; Pam Taub of the University of California, San Diego, in La Jolla, Calif.; and Blandine Laferrère of the Columbia University Irving Medical Center in New York, N.Y.

The study received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute on Aging, the National Cancer Institute, the Larry l. Hillblom Foundation, the Wu Tsai Human Performance Alliance, the U.S. Department of Defense and the Federal Emergency Management Agency.

The manuscript, “Time-Restricted Eating for the Prevention and Management of Metabolic Diseases,” was published online, ahead of print.

You may also like

  • New Study Questions BMI Accuracy in Childhood Obesity Screening

    A new study from the Avon Longitudinal Study of Parents and Children (ALSPAC) is challenging long-held assumptions about how we measure overweight and obesity in children. According to findings published in Obesity and Endocrinology in January 2025, body mass index (BMI) — the most commonly used tool for assessing weight status — may dramatically overestimate…

  • Endocrine Society Endorses Treat and Reduce Obesity Act

    The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.  The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law.  Access to these medications would benefit millions of Americans. More than…

Find more in